The Next Big Thing

Oliveda International, Inc. Announces New Waterless Beauty Products from Oliveda and Affiliated Brands

Retrieved on: 
Monday, July 10, 2023

Santa Monica, CA, July 10, 2023 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced new products in its waterless beauty lines by subsidiary, Olive Tree People, and its affiliated brands.

Key Points: 
  • Santa Monica, CA, July 10, 2023 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced new products in its waterless beauty lines by subsidiary, Olive Tree People, and its affiliated brands.
  • More information on the F86 Corrective Vegan Hyaluronic Serum Face and all products from Oliveda, LA Dope, and The Intuition brands can be found at https://us.olivetreepeople.com .
  • Preservatives on the skin can damage the microbiome and promote the inflammatory process and have hormonal effects.
  • Instead of refined/deodorized oils, Oliveda and all sister brands use cold-pressed Bioactive Arbequina Oil derived from their own eco-certified mountain olive trees.

Creator Deck Ranks on the 2022 Inc. 5000 Annual List of Fastest-Growing Companies

Retrieved on: 
Wednesday, August 17, 2022

NEW YORK, Aug. 17, 2022 /PRNewswire-PRWeb/ -- Today, Inc. revealed that Creator Deck is on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segment—its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Key Points: 
  • 355 Among America's Fastest-Growing Private Companies in Advertising & Marketing
    NEW YORK, Aug. 17, 2022 /PRNewswire-PRWeb/ -- Today, Inc. revealed that Creator Deck is on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.
  • The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segmentits independent businesses.
  • We are honored to be on this year's list of fastest-growing private companies in the US."
  • Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2018 to 2021.

TaiwanPlus Upholds Freedom of Speech in Asia with Docuseries Featuring “Fragile” Singer Namewee, Famously Banned in China

Retrieved on: 
Monday, April 4, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220403005028/en/
    Namewees behind-the-scenes story is exclusively available on TaiwanPlus.
  • (Photo: Business Wire)
    Road to Legacy is a TaiwanPlus Original Docuseries, showcasing 10 indie-music bands based in Taiwan.
  • The most recent case sees his music being banned in China due to the release of "Fragile, a single which many claimed to insult China by promoting independence for Hong Kong and Taiwan.
  • In Road to Legacy, he is shown passionately planning a major Taipei concert with songs that had been banned in other countries.

TaiwanPlus Upholds Freedom of Speech in Asia with Docuseries Featuring “Fragile” Singer Namewee, Famously Banned in China

Retrieved on: 
Monday, April 4, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220403005024/en/
    Namewees behind-the-scenes story is exclusively available on TaiwanPlus.
  • (Photo: Business Wire)
    Road to Legacy is a TaiwanPlus Original Docuseries, showcasing 10 indie-music bands based in Taiwan.
  • The most recent case sees his music being banned in China due to the release of "Fragile, a single which many claimed to insult China by promoting independence for Hong Kong and Taiwan.
  • In Road to Legacy, he is shown passionately planning a major Taipei concert with songs that had been banned in other countries.

Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual Meeting

Retrieved on: 
Wednesday, March 9, 2022

Adhesions can be found in up to 90% of cases after intra-abdominal surgery.

Key Points: 
  • Adhesions can be found in up to 90% of cases after intra-abdominal surgery.
  • We look forward to sharing additional data on the incidence and severity of adhesions from the pooled analysis of patients treated with LB1148.
  • Palisade Bios Chief Medical Officer, Michael Dawson, M.D., will present the data and be joined by one of the investigators of the study, Ronald Hurst, M.D.
  • Evidence suggests that the release of digestive proteases contributes to the temporary loss of normal gastrointestinal function and formation of postoperative adhesions.

Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting

Retrieved on: 
Wednesday, March 2, 2022

SAGES is one of the worlds premier professional organizations for gastrointestinal observation, early cancer detection screening and endoscopic surgery, which is our primary user market.

Key Points: 
  • SAGES is one of the worlds premier professional organizations for gastrointestinal observation, early cancer detection screening and endoscopic surgery, which is our primary user market.
  • Stella was the only diagnostics organization selected out of many GI-focused companies to present their assets, team, and path to market in front of SAGES members and judges.
  • Stella Diagnostics can give no assurances that any projections related to revenues, profit margins or profits will be realized.
  • Stella Diagnostics can give no assurances that any projections related to revenues, profit margins or profits will be realized.

Palisade Bio (Nasdaq: PALI) to Announce Adhesions Clinical Data at SAGES 2022 Annual Meeting

Retrieved on: 
Tuesday, February 8, 2022

Palisade Bios Chief Medical Officer, Michael Dawson, M.D., will present the data in a public webinar hosted by Stonegate Capital Partners the morning of March 16.

Key Points: 
  • Palisade Bios Chief Medical Officer, Michael Dawson, M.D., will present the data in a public webinar hosted by Stonegate Capital Partners the morning of March 16.
  • Studies LBS-IST-POI-101 and LBS-POI-201-CN (PROFILE-CN) assessed the efficacy of LB1148 to reduce the formation of adhesions in subjects undergoing abdominal surgery.
  • Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage.
  • Palisade Bio Investor Relations Contact:
    Palisade Bio Media Relations Contact:

Denver's Largest Real Estate Event, "The Next Big Thing," Will Feature Keynote Ryan Serhant of Million Dollar Listing New York

Retrieved on: 
Monday, January 10, 2022

1 producer at Fairway Independent Mortgage Corporation nationally, will host "The Next Big Thing," an industry-wide event featuring leaders and pioneers to discuss the future of real estate and how real estate professionals will define success.

Key Points: 
  • 1 producer at Fairway Independent Mortgage Corporation nationally, will host "The Next Big Thing," an industry-wide event featuring leaders and pioneers to discuss the future of real estate and how real estate professionals will define success.
  • The event will be held on Thursday, Jan. 20 and Friday, Jan. 21 at The Denver Marriott Westminster and is open for registration.
  • Headlining the event is keynote speaker, Ryan Serhant, real estate broker, CEO and founder of SERHANT., a vertically integrated mega brokerage comprising an in-house film studio, education arm, marketing division and technology platform.
  • He is also a best-selling author and star of Bravo's "Million Dollar Listing New York" and "Sell It Like Serhant."

ColoWrap Shortens Cecal Intubation Time During Colonoscopy -- Abstract Selected for Presentation at "The Next Big Thing" Session at SAGES 2021

Retrieved on: 
Wednesday, September 1, 2021

The study reviewed 452 procedures in which ColoWrap was used to compare the efficacy between first and second-generation ColoWrap devices.

Key Points: 
  • The study reviewed 452 procedures in which ColoWrap was used to compare the efficacy between first and second-generation ColoWrap devices.
  • This adjustable GEN 2 ColoWrap was associated with significantly faster cecal intubation time and reduced the need for ancillary maneuvers to less than 1 in 10 procedures.
  • Preventing looping and reducing cecal intubation time are paramount to delivering efficient, safe, and thorough examinations while also keeping patients, staff, and physicians protected.
  • The Company's flagship product, the ColoWrap Anti-Looping Colonoscopy Compression Device is the first and only non-invasive device that has been clinically proven to mitigate looping during colonoscopy.